Literature DB >> 2967404

Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma.

T Schroder1, I W Chen, M Sperling, R H Bell, K Brackett, S N Joffe.   

Abstract

Little information is currently available concerning the uptake of porphyrins by pancreatic tumors, or the effect of photodynamic therapy (PDT) on pancreatic cancer. In Syrian golden hamsters (n = 33), the organ distribution of 125I-labeled dihematoporphyrin ether (DHE) was studied in a pancreatic cancer model. In the same animal model the effect of PDT was studied using a gold vapor laser for energy delivery 3 hr after the injection of DHE (n = 7). DHE was 2.4 times more concentrated in the pancreatic tumor than in the nontumorous pancreas at 3 hr. Simultaneously there was a considerable accumulation of DHE in the surrounding gastrointestinal tract, causing perforation of the duodenum and jejunum with resultant death in four (57%) animals after PDT. Photodynamic therapy caused extensive tumor necrosis without any obvious effect on the nontumor-bearing pancreas. Damage to the surrounding tissue in the hamster indicates that precautions should be taken if PDT is to be used clinically in pancreatic cancer. Intratumoral injection of DHE may give higher drug concentrations with greater specificity for tumor treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967404     DOI: 10.1002/jso.2930380103

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.

Authors:  Luo-Wei Wang; Zheng Huang; Han Lin; Zhao-Shen Li; Fred Hetzel; Bolin Liu Md
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-01-30       Impact factor: 3.631

Review 2.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Photodynamic therapy for cancer of the pancreas.

Authors:  S G Bown; A Z Rogowska; D E Whitelaw; W R Lees; L B Lovat; P Ripley; L Jones; P Wyld; A Gillams; A W R Hatfield
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

4.  Characterization of the role of the photosensitizer, deuteporfin, in the detection of lymphatic metastases in a pancreatic cancer xenograft model.

Authors:  Xinzhe Yu; Hengchao Li; Deliang Fu; Chen Jin; J I Li
Journal:  Oncol Lett       Date:  2015-06-30       Impact factor: 2.967

Review 5.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

6.  Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.

Authors:  Zhiwei Hu; Benqiang Rao; Shimin Chen; Jinzhong Duanmu
Journal:  Breast Cancer Res Treat       Date:  2010-06-01       Impact factor: 4.872

7.  Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.

Authors:  Zhiwei Hu; Benqiang Rao; Shimin Chen; Jinzhong Duanmu
Journal:  BMC Cancer       Date:  2010-05-26       Impact factor: 4.430

8.  Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo.

Authors:  Qi Xie; Lin Jia; Yan-Hong Liu; Cheng-Gang Wei
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 9.  Photodynamic therapy in gastroenterology.

Authors:  N Shishkova; O Kuznetsova; T Berezov
Journal:  J Gastrointest Cancer       Date:  2013-09

10.  Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster.

Authors:  P J Nuutinen; P T Chatlani; J Bedwell; A J MacRobert; D Phillips; S G Bown
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.